跳至主要内容
临床试验/CTRI/2025/08/092818
CTRI/2025/08/092818尚未招募3 期

Aspirin Vs Placebo in pregnancies at high risk for pre-eclampsia:-A Randomized controlled trial

Dr Rajendra Prasad government medical college Kangra at Tanda1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2025年8月23日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
200
试验地点
1
主要终点
Delivery with pre eclampsia

研究概览

简要总结

Thesis for post graduation in ms obgy

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
19.00 Year(s) 至 39.00 Year(s)(—)
性别
Female

入选标准

  • Live fetus at gestational age 12 to 20 weeks, history of pre eclampsia, chronic hypertension, diabetes mellitus, Multi fetal gestation,nulliparity,obesity BMI more than 30, family, history of pre eclampsia.

排除标准

  • Allergy to aspirin , asthma,known case of peptic ulcers , severe heart,liver or renal disease and bleeding disorders,autoimmune diseases,mental disorders, history of alcohol or drug abuse within 6 months, conception after IVF.

结局指标

主要结局

Delivery with pre eclampsia

时间窗: Before at or after 37 weeks of gestation

次要结局

  • Fetomaternal out omes(As mentioned above)

研究者

发起方
Dr Rajendra Prasad government medical college Kangra at Tanda
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Shreya Mishra

Dr Rajendra Prasad government medical college Kangra at Tanda

研究点 (1)

Loading locations...

相似试验